Amiodarone-Induced Thyrotoxicosis

Author(s):
S BrogioniS Brogioni1, E DellUntoE DellUnto1, C CosciC Cosci1, L TomistiL Tomisti1, L BartalenaL Bartalena2, E MartinoE Martino3,*, F BogazziF Bogazzi1
1Department of Endocrinology and Metabolism, University of Pisa, Italy
2Departmentof Clinical Medicine, University of Insubria, Italy
3Department of Endocrinology and Metabolism, University of Pisa, [email protected], Italy

International Journal of Endocrinology and Metabolism:Vol. 4, issue 1; 52-62
Published online:Jan 31, 2006
Article type:Review Article
Received:Jan 01, 2005
Accepted:Dec 01, 2005
How to Cite:Brogioni S, DellUnto E, Cosci C, Tomisti L, Bartalena L, et al. Amiodarone-Induced Thyrotoxicosis. Int J Endocrinol Metab. 2006;4(1):. doi:

Abstract

Full Text

Full text is available in PDF

Similar Articles

31
Oct
2006

Thionamide Associated Agranulocytosis: Low Incidence with Low Doses of Methimazole

A Bahrami

Bahrami A. Thionamide Associated Agranulocytosis: Low Incidence with Low Doses of Methimazole. Int J Endocrinol Metab. 2006;4(4):. doi:

29
Sep
2012

Recombinant TSH and Lithium Overcomes Amiodarone-Induced Low Radioiodine Uptake in a Thyrotoxic Female

Nestor Eric R. Laplano,
Leilani B. Mercado-Asis

Laplano NER, Mercado-Asis LB. Recombinant TSH and Lithium Overcomes Amiodarone-Induced Low Radioiodine Uptake in a Thyrotoxic Female. Int J Endocrinol Metab. 2012;10(4):. doi: https://doi.org/10.5812/ijem.5406

1
Apr
2014

Surgical Management of an Atypical Presentation of a Thyroid Storm

Ricardo Mario Aulet,
Richard O. Wein,
Richard D. Siegel

Aulet RM, Wein RO, Siegel RD. Surgical Management of an Atypical Presentation of a Thyroid Storm. Int J Endocrinol Metab. 2014;12(2):e13539. doi: https://doi.org/10.5812/ijem.13539

31
Dec
2019

Antithyroid Drugs

Hengameh Abdi,
Atieh Amouzegar,
Fereidoun Azizi

Abdi H, Amouzegar A, Azizi F. Antithyroid Drugs. Iran J Pharm Res. 2019;18(Suppl1):e124684. doi: https://doi.org/10.22037/ijpr.2020.112892.14005

13
Jun
2020
International Journal of Endocrinology and Metabolism

Remission Rate of Graves' Disease and the Trend of Changes in Serum TSH Receptor Antibodies in Prolonged Antithyroid Drug Treatment

Danilo Villagelin,
Roberto Bernardo Santos,
João Hamilton Romaldini

Villagelin D, Santos RB, Romaldini JH. Remission Rate of Graves' Disease and the Trend of Changes in Serum TSH Receptor Antibodies in Prolonged Antithyroid Drug Treatment. Int J Endocrinol Metab. 2020;18(Suppl):e101473. doi: https://doi.org/10.5812/ijem.101473

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles